Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dabouis

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Anti-Cancer Drugs|December 1, 1995
Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II studyW P Steward, D J Dunlop, C Cameron, et al.
Cancer|August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 yearsM Paesmans, J P Sculier, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practiceK Mattson, L Bosquee, G Dabouis, et al.
Revue Des Maladies Respiratoires|March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]J P Sculier, M Paesmans, P Libert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II studyJ-Y Douillard, R Gervais, G Dabouis, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 9, 2022
Experiences of parents and caregivers in pediatric intensive care units: A qualitative studyG Durand, B Branger, V Durier, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)M Borges, J P Sculier, M Paesmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1G Robinet, P Thomas, J L Breton, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Anti-Cancer Drugs|December 1, 1995
Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II studyW P Steward, D J Dunlop, C Cameron, et al.
Cancer|August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 yearsM Paesmans, J P Sculier, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practiceK Mattson, L Bosquee, G Dabouis, et al.
Revue Des Maladies Respiratoires|March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]J P Sculier, M Paesmans, P Libert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II studyJ-Y Douillard, R Gervais, G Dabouis, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 9, 2022
Experiences of parents and caregivers in pediatric intensive care units: A qualitative studyG Durand, B Branger, V Durier, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)M Borges, J P Sculier, M Paesmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1G Robinet, P Thomas, J L Breton, et al.
Pageof 6